Authors:
Everett, SA
Naylor, MA
Barraja, P
Swann, E
Patel, KB
Stratford, MRL
Hudnott, AR
Vojnovic, B
Locke, RJ
Wardman, P
Moody, CJ
Citation: Sa. Everett et al., Controlling the rates of reductively-activated elimination from the (indol-3-yl)methyl position of indolequinones, J CHEM S P2, (5), 2001, pp. 843-860
Authors:
Galbraith, SM
Chaplin, DJ
Lee, F
Stratford, MRL
Locke, RJ
Vojnovic, B
Tozer, GM
Citation: Sm. Galbraith et al., Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo, ANTICANC R, 21(1A), 2001, pp. 93-102
Authors:
Peng, SX
Folkard, M
Gilchrist, S
Locke, RJ
Yu, ZL
Michael, BD
Citation: Sx. Peng et al., Measurements of the targeting accuracy of the Gray Laboratory charged-particle microbeam, NUCL INST B, 179(1), 2001, pp. 145-150
Authors:
Tozer, GM
Prise, VE
Wilson, J
Locke, RJ
Vojnovic, B
Stratford, MRL
Dennis, MF
Chaplin, DJ
Citation: Gm. Tozer et al., Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues, CANCER RES, 59(7), 1999, pp. 1626-1634